Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice

Journal of Clinical Investigation

Volumn 118, Issue 11, 2008, Pages 3619-3628

  Tsang, Julia Yuen Shan ^a   Tanriver, Yakup ^a   Jiang, Shuiping ^a   Xue, Shao An ^b   Ratnasothy, Kulachelvy ^a   Chen, Daxin ^c   Stauss, Hans J ^b   Bucy, R Pat ^d   Lombardi, Giovanna ^a   Lechler, Robert ^a,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d University of Alabama at Birmingham   (United States)

^e GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; GENE TRANSFER; GRAFT SURVIVAL; HEART GRAFT; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TRANSPLANTATION TOLERANCE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CROSSES, GENETIC; GENE TRANSFER TECHNIQUES; GENES, T-CELL RECEPTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; RETROVIRIDAE; T-LYMPHOCYTES, REGULATORY; TRANSDUCTION, GENETIC; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 55849142632     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33185     Document Type: Article

References (38)

1. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531-562.
2. Taylor, P.A., Lees, C.J., and Blazar, B.R. 2002. The infusion of ex vivo activated and expanded CD4(+) CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 99:3493-3499.
3. Cohen, J.L., Trenado, A., Vasey, D., Klatzmann, D., and Salomon, B.L. 2002. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J. Exp. Med. 196:401-406.
4. Cohen, J.L., and Boyer, O. 2006. The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease. Curr. Opin. Immunol. 18:580-585.
5. Graca, L., Cobbold, S.P., and Waldmann, H. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195:1641-1646.
6. Hara, M., et al. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166:3789-3796.
7. Rogers, N.J., and Lechler, R.I. 2001. Allorecognition. Am. J. Transplant. 1:97-102.
8. Hornick, P.I., et al. 2000. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation. 101:2405-2410.
9. Baker, R.J., et al. 2001. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J. Immunol. 167:7199-7206.
10. Wise, M.P., Bemelman, F., Cobbold, S.P., and Waldmann, H. 1998. Linked suppression of skin graft rejection can operate through indirect recognition. J. Immunol. 161:5813-5816.
11. Sanchez-Fueyo, A., et al. 2007. Influence of direct and indirect allorecognition pathways on CD4(+) CD25(+) regulatory T-cell function in transplantation. Transpl. Int. 20:534-541.
12. Jiang, S., Camara, N., Lombardi, G., and Lechler, R.I. 2003. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood. 102:2180-2186.
13. Golshayan, D., et al. 2007. In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood. 109:827-835.
14. Tsang, J., et al. 2006. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity. Int. Immunopharmacol. 6:1883-1888.
15. Jiang, S., et al. 2006. Generation and expansion of human CD4+ CD25+ regulatory T cells with indirect allospecificity: Potential reagents to promote donor-specific transplantation tolerance. Transplantation. 82:1738-1743.
16. Honjo, K., Xu, X.Y., and Bucy, R.P. 2000. Heterogeneity of T cell clones specific for a single indirect alloantigenic epitope (I-Ab/H-2Kd54-68) that mediate transplant rejection. Transplantation. 70:1516-1524.
17. Honjo, K., Xu, X., and Bucy, R.P. 2004. CD4+ T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition. Transplantation. 77:452-455.
18. Siegmund, K., et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood. 106:3097-3104.
19. Zheng, X.X., et al. 2003. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity. 19:503-514.
20. Xia, G., He, J., Zhang, Z., and Leventhal, J.R. 2006. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells. Transplantation. 82:1749-1755.
21. Karim, M., Feng, G., Wood, K.J., and Bushell, A.R. 2005. CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. Blood. 105:4871-4877.
22. Joffre, O., et al. 2008. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat. Med. 14:88-92.
23. Nikolaeva, N., Bemelman, F.J., Yong, S.L., van Lier, R.A., and ten Berge, I.J. 2006. Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells. Transplantation. 81:445-454.
24. Strauss, L., et al. 2007. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J. Immunol. 178:320-329.
25. Valmori, D., et al. 2006. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J. Immunol. 177:944-949.
26. Battaglia, M., Stabilini, A., and Roncarolo, M.G. 2005. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood. 105:4743-4748.
27. Jiang, S., Herrera, O., and Lechler, R.I. 2004. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr. Opin. Immunol. 16:550-557.
28. Morgan, R.A., et al. 2006. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science. 314:126-129.
29. Masteller, E.L., et al. 2005. Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol. 175:3053-3059.
30. Rubinstein, M.P., et al. 2003. Transfer of TCR genes into mature T cells is accompanied by the maintenance of parental T cell avidity. J. Immunol. 170:1209-1217.
31. Schaft, N., et al. 2003. Peptide fine specificity of anti-glycoprotein 100 CTL is preserved following transfer of engineered TCR alpha beta genes into primary human T lymphocytes. J. Immunol. 170:2186-2194.
32. Rezvani, K., et al. 2006. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood. 108:1291-1297.
33. Hanash, A.M., and Levy, R.B. 2005. Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood. 105:1828-1836.
34. Read, S., Malmstrom, V., and Powrie, F. 2000. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295-302.
35. Wells, A.D., Li, X.C., Strom, T.B., and Turka, L.A. 2001. The role of peripheral T-cell deletion in transplantation tolerance. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356:617-623.
36. Inaba, K., et al. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
37. Willemsen, R.A., et al. 2000. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther. 7:1369-1377.
38. Niimi, M. 2001. The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon. J. Heart Lung Transplant. 20:1123-1128.